![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RFX8 |
Gene summary for RFX8 |
![]() |
Gene information | Species | Human | Gene symbol | RFX8 | Gene ID | 731220 |
Gene name | regulatory factor X8 | |
Gene Alias | RFX8 | |
Cytomap | 2q11.2 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q6ZV50 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
731220 | RFX8 | ATC12 | Human | Thyroid | ATC | 2.56e-35 | 6.72e-01 | 0.34 |
731220 | RFX8 | ATC3 | Human | Thyroid | ATC | 6.43e-04 | 3.22e-01 | 0.338 |
731220 | RFX8 | ATC4 | Human | Thyroid | ATC | 1.50e-41 | 8.08e-01 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
RFX8 | MSC | Cervix | CC | MMP11,IGFBP3,MMP14, etc. | 5.34e-01 | ![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RFX8 | SNV | Missense_Mutation | novel | c.1267N>C | p.Asp423His | p.D423H | Q6ZV50 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-A7-A3IZ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD |
RFX8 | SNV | Missense_Mutation | c.685G>C | p.Ala229Pro | p.A229P | Q6ZV50 | protein_coding | tolerated(0.33) | benign(0.006) | TCGA-AN-A0AT-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
RFX8 | SNV | Missense_Mutation | novel | c.199N>T | p.Asp67Tyr | p.D67Y | Q6ZV50 | protein_coding | deleterious(0) | probably_damaging(0.912) | TCGA-BH-A0B6-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
RFX8 | insertion | Nonsense_Mutation | novel | c.848_849insAGGAGCTTGAGG | p.Ala283_Ala284insGlyAlaTerGly | p.A283_A284insGA*G | Q6ZV50 | protein_coding | TCGA-A8-A06Q-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | ||
RFX8 | SNV | Missense_Mutation | novel | c.72G>T | p.Lys24Asn | p.K24N | Q6ZV50 | protein_coding | deleterious(0.01) | probably_damaging(0.998) | TCGA-C5-A7UI-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
RFX8 | SNV | Missense_Mutation | c.1270N>A | p.Glu424Lys | p.E424K | Q6ZV50 | protein_coding | tolerated(1) | benign(0) | TCGA-A6-5667-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | oxaliplatin | SD | |
RFX8 | SNV | Missense_Mutation | c.593N>A | p.Arg198His | p.R198H | Q6ZV50 | protein_coding | tolerated(0.08) | possibly_damaging(0.88) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
RFX8 | SNV | Missense_Mutation | novel | c.245A>G | p.Asp82Gly | p.D82G | Q6ZV50 | protein_coding | tolerated(0.17) | possibly_damaging(0.613) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
RFX8 | SNV | Missense_Mutation | novel | c.760N>A | p.Leu254Ile | p.L254I | Q6ZV50 | protein_coding | tolerated(0.83) | benign(0.189) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
RFX8 | SNV | Missense_Mutation | c.561N>T | p.Lys187Asn | p.K187N | Q6ZV50 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AD-6889-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | xeloda | PD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |